Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Manchester-Nashua, NH Metro Edition
Focus: LIFE SCI
2.7%
Hillsborough County unemployment
June 2026, vs 4.1% national rate
6.1%
Hillsborough avg weekly wage growth
Highest among large NH counties, YoY
$130,450 vs $90,956
CRA advertised pay, metro vs national
Metro running 43% above national median
300-400 roles
Lonza Portsmouth planned headcount add
By end-2027, across mfg/quality/support
This Month's Takeaways
Metro median of $130,450 sits 43% above the $90,956 national figure, a reversal that suggests Manchester-area sponsors and CROs are paying a local scarcity premium rather than following national rate trends. Benchmarking this role against national data alone would understate retention risk.
Adding 300-400 roles split across manufacturing, quality, and support by 2027 gives Lonza outsized influence over local technician and quality-role pay floors. Smaller biotech and device employers nearby should expect upward pressure on entry- and mid-level manufacturing compensation regardless of their own hiring plans.
Metro median advertised pay of $105,402 has edged past the $104,000 national figure, consistent with national reporting that experienced regulatory professionals are in short global supply. Given VP-level regulatory pay nationally reaching $320K-$580K, mid-career regulatory retention may deserve more attention than headcount expansion at the top.
Metro median pay fell to $112,177, tracking a national decline to $123,031, even as most clinical and regulatory roles in the metro show upward pressure. This divergence may reflect automation or offshoring absorption in data management functions ahead of other specialties — worth testing before assuming uniform talent tightness across clinical operations.
Local Labor Conditions
Hillsborough County unemployment sits near 2.7-3.0% while average weekly wages climbed 6.1% year-over-year, reflecting a metro where healthcare and life sciences employment expansion collides with a shrinking pool of manufacturing-adjacent technical talent. Lonza's Portsmouth facility plans to add 300-400 workers by end-2027 across manufacturing, quality, and support functions, intensifying competition for exactly the technician and engineering profiles the state's own workforce economists describe as structurally undersupplied.
Leadership & Talent Implications
Metro-level Clinical Research Associate pay has pulled sharply ahead of national median ($130,450 vs $90,956), and Regulatory Affairs Specialist advertised pay now exceeds the national figure as well — both signals that Manchester-area employers are bidding aggressively for credentialed talent rather than relying on organic labor supply growth. With UNH researchers describing a 'talent alignment problem' rather than a shortage, build-vs-outsource decisions should weigh whether CDMO/CRO partnerships can absorb technician and supply-chain gaps faster than internal pipeline investment; current conditions suggest reviewing regulatory and clinical compensation bands against Lonza's anchor-tenant wage floor before losing mid-career staff to a 300-400 person hiring wave next door.
Advertised Pay Indicators
| Role | P25 | Median | P75 | Local Trend | National | Nat. Trend |
|---|---|---|---|---|---|---|
| Research Scientist | — | — | — | — No data | $131,354 | ↑ Significant increase |
| Clinical Research Associate | $130,450 | $130,450 | $130,450 | ↑ Significant increase | $90,956 | ↑ Significant increase |
| Lab Technician | $42,723 | $52,416 | $57,070 | ↑ Moderate increase | $47,402 | ↓ Moderate decline |
| Regulatory Affairs Specialist | $87,255 | $105,402 | $105,402 | ↑ Significant increase | $104,000 | → Stable |
| Clinical Data Manager | — | — | — | — No data | $123,031 | ↓ Moderate decline |
| Biostatistician | $156,421 | $156,466 | $159,623 | ↑ Moderate increase | $133,322 | ↑ Moderate increase |
| Validation Engineer | $98,292 | $103,666 | $106,144 | → Stable | $108,377 | ↑ Moderate increase |
Some roles reflect state-level data where local metro sample size was insufficient.
Looking Ahead · Next 30–60 Days
Expected
Lonza's phased hiring toward 300-400 net new roles by end-2027 will likely begin showing in local job postings volume this quarter. Watch whether competing manufacturers and device makers respond with pay adjustments before losing incumbent technicians.
Emerging pressure point
Ongoing unemployment claims statewide are running 23% above the same period two years ago despite a 2.8% headline rate, suggesting friction in matching displaced workers to open life sciences roles. Technician and supply-chain openings may persist even as claims rise, reinforcing the alignment-problem thesis over a shortage narrative.
Worth watching
NH-LIFT workforce pipeline initiatives remain 18-24 months from measurable hiring impact, meaning near-term technician and engineer gaps will not be resolved through training pipelines this cycle. Build-vs-outsource calculus should assume current scarcity persists through at least 2027.
Potential inflection point
National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions while 64% of surveyed organizations keep recruiting, a pattern that could release mid-career talent into regional candidate pools. Monitor whether any laid-off specialists from larger national employers surface in Manchester-area applicant flow.
WageScape Member Benefit
Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.
Pulse Plus
3 metro reports
$149/year
Pulse Pro
10 metro reports
$349/year
Enterprise
10+ markets
Contact us
WageTrak · 15% Member Discount
On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.
Forwarded This Briefing?
Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.